These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24449771)

  • 21. Stationary-Phase Persisters to Ofloxacin Sustain DNA Damage and Require Repair Systems Only during Recovery.
    Völzing KG; Brynildsen MP
    mBio; 2015 Sep; 6(5):e00731-15. PubMed ID: 26330511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATP-Dependent Persister Formation in Escherichia coli.
    Shan Y; Brown Gandt A; Rowe SE; Deisinger JP; Conlon BP; Lewis K
    mBio; 2017 Feb; 8(1):. PubMed ID: 28174313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medium chain unsaturated fatty acid ethyl esters inhibit persister formation of Escherichia coli via antitoxin HipB.
    Wang M; Fang K; Hong SMC; Kim I; Jang IS; Hong SH
    Appl Microbiol Biotechnol; 2018 Oct; 102(19):8511-8524. PubMed ID: 30088019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic AMP Regulates Bacterial Persistence through Repression of the Oxidative Stress Response and SOS-Dependent DNA Repair in Uropathogenic
    Molina-Quiroz RC; Silva-Valenzuela C; Brewster J; Castro-Nallar E; Levy SB; Camilli A
    mBio; 2018 Jan; 9(1):. PubMed ID: 29317513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ciprofloxacin-induced persister-cells in
    Ovsepian A; Larsen MH; Vegge CS; Ingmer H
    Microbiology (Reading); 2020 Sep; 166(9):849-853. PubMed ID: 32697188
    [No Abstract]   [Full Text] [Related]  

  • 26. Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells.
    Goormaghtigh F; Fraikin N; Putrinš M; Hallaert T; Hauryliuk V; Garcia-Pino A; Sjödin A; Kasvandik S; Udekwu K; Tenson T; Kaldalu N; Van Melderen L
    mBio; 2018 Jun; 9(3):. PubMed ID: 29895634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic Efficacy in Escherichia coli and Klebsiella pneumoniae Under Nutrient Limitation and Effectiveness of Colistin-Based Antibiotic Combinations to Eradicate Persister Cells.
    Seo J; Na IY; Ko KS
    Curr Microbiol; 2023 Dec; 81(1):34. PubMed ID: 38064019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli.
    Hansen S; Lewis K; Vulić M
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2718-26. PubMed ID: 18519731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose sensitizes the stationary and persistent population of Vibrio cholerae to ciprofloxacin.
    Paranjape SS; Shashidhar R
    Arch Microbiol; 2020 Mar; 202(2):343-349. PubMed ID: 31664493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High persister cell formation by clinical
    Liu L; Wang Y; Bojer MS; Andersen PS; Ingmer H
    Microbiology (Reading); 2020 Jul; 166(7):654-658. PubMed ID: 32427093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli.
    López E; Blázquez J
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3411-5. PubMed ID: 19487441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stochastic Variation in Expression of the Tricarboxylic Acid Cycle Produces Persister Cells.
    Zalis EA; Nuxoll AS; Manuse S; Clair G; Radlinski LC; Conlon BP; Adkins J; Lewis K
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics.
    Defraine V; Fauvart M; Michiels J
    Drug Resist Updat; 2018 May; 38():12-26. PubMed ID: 29857815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resuscitation dynamics reveal persister partitioning after antibiotic treatment.
    Fang X; Allison KR
    Mol Syst Biol; 2023 Apr; 19(4):e11320. PubMed ID: 36866643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic Study of the Survival and Resuscitation Mechanisms of Filamentous Persisters in an Evolved Escherichia coli Population from Cyclic Ampicillin Treatment.
    Sulaiman JE; Lam H
    mSystems; 2020 Jul; 5(4):. PubMed ID: 32723793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteolytic Queues at ClpXP Increase Antibiotic Tolerance.
    Deter HS; Abualrahi AH; Jadhav P; Schweer EK; Ogle CT; Butzin NC
    ACS Synth Biol; 2020 Jan; 9(1):95-103. PubMed ID: 31860281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Energy production genes sucB and ubiF are involved in persister survival and tolerance to multiple antibiotics and stresses in Escherichia coli.
    Ma C; Sim S; Shi W; Du L; Xing D; Zhang Y
    FEMS Microbiol Lett; 2010 Feb; 303(1):33-40. PubMed ID: 20041955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival of bactericidal antibiotic treatment by tolerant persister cells of Klebsiella pneumoniae.
    Li Y; Zhang L; Zhou Y; Zhang Z; Zhang X
    J Med Microbiol; 2018 Mar; 67(3):273-281. PubMed ID: 29458540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxin Induction or Inhibition of Transcription or Translation Posttreatment Increases Persistence to Fluoroquinolones.
    Lemma AS; Brynildsen MP
    mBio; 2021 Aug; 12(4):e0198321. PubMed ID: 34399616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reverting antibiotic tolerance of Pseudomonas aeruginosa PAO1 persister cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one.
    Pan J; Bahar AA; Syed H; Ren D
    PLoS One; 2012; 7(9):e45778. PubMed ID: 23029239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.